Infections with antibiotic-resistant bacteria combined with breast or colon cancer lead to the majority of deaths worldwide. As fast and reliable diagnostic methods enable a timely and specifically effective treatment in such cases, they are invaluable. The FasterPCR Project (fast automated diagnostic system targeting severe resistant pathogens and cancer) is aimed at a point-of-care system that facilitates the non-invasive testing of the presence both breast cancer and colon cancer DNA and of multi-resistant bacteria in the body. The system is fully automated and consists of a processing unit and inexpensive disposable prototypes. The analysis of patient specimens directly on-site prevents delays and the logistical expenditure incurred by the transportation of specimens to a central laboratory. Physicians are given a powerful diagnostics tool that can detect serious infections or cancer at an early stage, allowing them to initiate treatment that is tailored to a specific type of cancer or bacterial resistance.back to overview
|Promoter:||Project Management Jülich|
|Duration:||01.02.2015 to 31.08.2018|
|Cooperation Partner:||Altona Diagnostics GmbH, Datamed srl, E.L.T Werkzeugbau GmbH, StemTek Therapeutics, Fraunhofer-Institut für physikalische Messtechnik IPM|
Article at Healthcare industry BW: "New diagnostic tool for greater health safety when dealing with multidrug-resistant pathogens"